Integrated Diagnostics Holdings PLC
LSE:IDHC

Watchlist Manager
Integrated Diagnostics Holdings PLC Logo
Integrated Diagnostics Holdings PLC
LSE:IDHC
Watchlist
Price: 0.435 USD -3.12% Market Closed
Market Cap: 252.9m USD
Have any thoughts about
Integrated Diagnostics Holdings PLC?
Write Note

Integrated Diagnostics Holdings PLC
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Integrated Diagnostics Holdings PLC
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Integrated Diagnostics Holdings PLC
LSE:IDHC
Cash from Financing Activities
-egp243.9m
CAGR 3-Years
26%
CAGR 5-Years
11%
CAGR 10-Years
N/A
No Stocks Found

Integrated Diagnostics Holdings PLC
Glance View

Market Cap
261m USD
Industry
Health Care

Integrated Diagnostics Holdings Plc engages in the provision of diagnostics services including pathology and molecular diagnostics, genetics testing and basic radiology to patients and other laboratories. The firm operates in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The company is engaged in offering services in immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology and radiology. Its brands include Al Borg, Al Borg Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Ultralab and Al Mokhtabar Sudan (both in Sudan), and Echo-Lab (Nigeria). The company operates in approximately 507 branches. IDH offers 2,000 diagnostic pathology tests ranging from routine to advanced. Its common tests include those for cholesterol, diabetes, pregnancy, and substance abuse. Through Al Borg Scan, it offers a range of radiology services, including but not limited to magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, x-ray, mammograms, cath lab facilities, and positron emission tomography-computed tomography (PET-CT).

IDHC Intrinsic Value
0.583 USD
Undervaluation 25%
Intrinsic Value
Price

See Also

What is Integrated Diagnostics Holdings PLC's Cash from Financing Activities?
Cash from Financing Activities
-243.9m EGP

Based on the financial report for Jun 30, 2024, Integrated Diagnostics Holdings PLC's Cash from Financing Activities amounts to -243.9m EGP.

What is Integrated Diagnostics Holdings PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
11%

Over the last year, the Cash from Financing Activities growth was 85%. The average annual Cash from Financing Activities growth rates for Integrated Diagnostics Holdings PLC have been 26% over the past three years , 11% over the past five years .

Back to Top